NEULASTA
Google image searchProduct monograph
Active ingredient
pegfilgrastim, 10 MG/ML
DIN: 02249790
Dosage form(s): SOLUTION
Route(s) of administration: SUBCUTANEOUS
Schedule: Prescription / Schedule D
Company: AMGEN CANADA INC
Date: 12-MAR-2004
ATC:
- L03 — IMMUNOSTIMULANTS (ATC, ATC/DDD, )
- L03A — IMMUNOSTIMULANTS (ATC, ATC/DDD)
- L03AA — Colony stimulating factors (ATC, ATC/DDD)
- L03AA13 — PEGFILGRASTIM (ATC/DDD)
Reference brand drug: Neulasta
